1
|
Temel H, Atlan M, Türkmenoğlu B, Ertaş A, Erdönmez D, Çalışkan UK. In silico and biological activity evaluation of quercetin-boron hybrid compounds, anti-quorum sensing effect as alternative potential against microbial resistance. J Trace Elem Med Biol 2023; 77:127139. [PMID: 36791625 DOI: 10.1016/j.jtemb.2023.127139] [Citation(s) in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/31/2022] [Revised: 02/01/2023] [Accepted: 02/07/2023] [Indexed: 02/12/2023]
Abstract
Boronic acid compounds and the natural flavonoid compound quercetin were handled to synthesize two novel ligands encoded as B1(2,2'-(1,4-phenylenebis (benzo [1,3,2] dioxaborole-2,5-diyl)) bis (3,5,7-trihydroxy-4H- chromen-4-one) and B2(3.3.6. 3,5,7-trihydroxy-2-(2-(6-methoxypyridin-3-yl)benzo[d][1,3,2]dioxaborol-5-yl)- 4 H-chromene-4). Antioxidant activities of ligands were investigated by DPPH, ABTS and CUPRAC methods. Cholinesterase inhibition effects of ligands were determined by acetylcholinesterase and butyrylcholinesterase enzyme inhibition methods, cytotoxic effects of ligands were applied to healthy breast and colon cancer cell lines by MTT method, and urease and tyrosinase enzyme activities were determined. Antimicrobial properties of the compounds were analyzed by detecting their anti-QS potentials on Chromobacterium violaceum biosensor strain. Both compounds were found to have significant antioxidant effects compared to controls. It was determined that the compound B1 at 1-10 µg/mL was more active than the reference compounds (α-TOC and BHT). Moreover, the enzyme activity studies on ligands demonstrated that acetylchoinesterase and butyrylcholinesterase enzyme inhibitions were higher than the reference compounds. As expected, boron derivatives exhibited respectable activity against the biofilms of Escherichia coli (E. coli) and P. aeruginosa (P. aeruginosa). These results demonstrate the potential applicability of boron derivatives in the treatment of biofilm-associated infections and provide a practical strategy for the design of new boron-based antimicrobial materials. In silico molecular docking studies were performed on ligands to identify newly synthesized compounds. The binding parameter values and binding sites of the compounds were also determined. In conclusion, our studies showed that newly synthesized hybrid compounds could be solutions for antimicrobial resistance and enzyme-related disorders.
Collapse
Affiliation(s)
- Hamdi Temel
- Department of Chemistry, Institute of Science, Dicle University, 21280 Diyarbakir, Turkey; Department of Medical Pharmacology, Faculty of Medicine, Yozgat Bozok University, 66000 Yozgat, Turkey.
| | - Metin Atlan
- Department of Chemistry, Institute of Science, Dicle University, 21280 Diyarbakir, Turkey
| | - Burçin Türkmenoğlu
- Department of Analytical Chemistry, Faculty of Pharmacy, Erzincan Binali Yıldırım University, 24002, Erzincan, Turkey
| | - Abdulselam Ertaş
- Department of Analytical Chemistry, Faculty of Pharmacy, Dicle University, 21280 Diyarbakir, Turkey
| | - Demet Erdönmez
- Department of Pharmaceutical Microbiology, Faculty of Pharmacy, Düzce University, 81620 Düzce, Turkey
| | - Ufuk Koca Çalışkan
- Department of Pharmacognosy, Faculty of Pharmacy, Gazi University, 06570 Ankara, Turkey
| |
Collapse
|
2
|
Smith N, Quan D, Nagalingam G, Triccas JA, Rendina LM, Rutledge PJ. Carborane clusters increase the potency of bis-substituted cyclam derivatives against Mycobacterium tuberculosis. RSC Med Chem 2022; 13:1234-1238. [PMID: 36325397 PMCID: PMC9579921 DOI: 10.1039/d2md00150k] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/20/2022] [Accepted: 07/28/2022] [Indexed: 08/04/2023] Open
Abstract
Bis-substituted cyclam derivatives have recently emerged as a promising new class of antibacterial agents, displaying excellent activity against drug-resistant Mycobacterium tuberculosis (Mtb) and in vivo efficacy in a zebrafish assay. Herein we report the synthesis and biological activity of new carborane derivatives within this class of antitubercular compounds. The resulting carborane-cyclam conjugates incorporating either hydrophobic closo-1,2-carborane or anionic, hydrophilic nido-7,8-carborane clusters display promising activity in an antibacterial assay employing the virulent Mtb strain H37Rv. The most active of these carborane derivatives exhibit MIC50 values of <1 μM, making them the most active compounds in this unique class of antibacterial cyclams reported to date.
Collapse
Affiliation(s)
- Nicholas Smith
- School of Chemistry, The University of Sydney Sydney NSW 2006 Australia +61 2 9351 5020 +61 2 9351 4781
| | - Diana Quan
- Sydney Institute of Infectious Diseases and Charles Perkins Centre, The University of Sydney Sydney NSW 2006 Australia
- School of Medical Sciences, The University of Sydney Sydney NSW 2006 Australia
| | - Gayathri Nagalingam
- Sydney Institute of Infectious Diseases and Charles Perkins Centre, The University of Sydney Sydney NSW 2006 Australia
- School of Medical Sciences, The University of Sydney Sydney NSW 2006 Australia
| | - James A Triccas
- Sydney Institute of Infectious Diseases and Charles Perkins Centre, The University of Sydney Sydney NSW 2006 Australia
- School of Medical Sciences, The University of Sydney Sydney NSW 2006 Australia
| | - Louis M Rendina
- School of Chemistry, The University of Sydney Sydney NSW 2006 Australia +61 2 9351 5020 +61 2 9351 4781
- The University of Sydney Nano Institute (Sydney Nano), The University of Sydney Sydney NSW 2006 Australia
| | - Peter J Rutledge
- School of Chemistry, The University of Sydney Sydney NSW 2006 Australia +61 2 9351 5020 +61 2 9351 4781
| |
Collapse
|
3
|
Estevez-Fregoso E, Farfán-García ED, García-Coronel IH, Martínez-Herrera E, Alatorre A, Scorei RI, Soriano-Ursúa MA. Effects of boron-containing compounds in the fungal kingdom. J Trace Elem Med Biol 2021; 65:126714. [PMID: 33453473 DOI: 10.1016/j.jtemb.2021.126714] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/27/2020] [Revised: 12/10/2020] [Accepted: 01/04/2021] [Indexed: 02/07/2023]
Abstract
BACKGROUND The number of known boron-containing compounds (BCCs) is increasing due to their identification in nature and innovative synthesis procedures. Their effects on the fungal kingdom are interesting, and some of their mechanisms of action have recently been elucidated. METHODS In this review, scientific reports from relevant chemistry and biomedical databases were collected and analyzed. RESULTS It is notable that several BCC actions in fungi induce social and economic benefits for humans. In fact, boric acid was traditionally used for multiple purposes, but some novel synthetic BCCs are effective antifungal agents, particularly in their action against pathogen species, and some were recently approved for use in humans. Moreover, most reports testing BCCs in fungal species suggest a limiting effect of these compounds on some vital reactions. CONCLUSIONS New BCCs have been synthesized and tested for innovative technological and biomedical emerging applications, and new interest is developing for discovering new strategic compounds that can act as environmental or wood protectors, as well as antimycotic agents that let us improve food acquisition and control some human infections.
Collapse
Affiliation(s)
- Elizabeth Estevez-Fregoso
- Sección de Estudios de Posgrado e Investigación, Escuela Superior de Medicina, Instituto Politécnico Nacional, Plan de San Luis y Díaz Mirón, 11340, Mexico
| | - Eunice D Farfán-García
- Sección de Estudios de Posgrado e Investigación, Escuela Superior de Medicina, Instituto Politécnico Nacional, Plan de San Luis y Díaz Mirón, 11340, Mexico.
| | - Itzel H García-Coronel
- Sección de Estudios de Posgrado e Investigación, Escuela Superior de Medicina, Instituto Politécnico Nacional, Plan de San Luis y Díaz Mirón, 11340, Mexico; Unidad de Investigación, Hospital Regional de Alta Especialidad Ixtapaluca, Carretera Federal México-Puebla km 34.5, C.P. 56530, Ixtapaluca, State of Mexico, Mexico
| | - Erick Martínez-Herrera
- Unidad de Investigación, Hospital Regional de Alta Especialidad Ixtapaluca, Carretera Federal México-Puebla km 34.5, C.P. 56530, Ixtapaluca, State of Mexico, Mexico
| | - Alberto Alatorre
- Sección de Estudios de Posgrado e Investigación, Escuela Superior de Medicina, Instituto Politécnico Nacional, Plan de San Luis y Díaz Mirón, 11340, Mexico
| | - Romulus I Scorei
- BioBoron Research Institute, Dunarii 31B Street, 207465, Podari, Romania
| | - Marvin A Soriano-Ursúa
- Sección de Estudios de Posgrado e Investigación, Escuela Superior de Medicina, Instituto Politécnico Nacional, Plan de San Luis y Díaz Mirón, 11340, Mexico.
| |
Collapse
|
4
|
Tevyashova AN, Chudinov MV. Progress in the medicinal chemistry of organoboron compounds. RUSSIAN CHEMICAL REVIEWS 2021. [DOI: 10.1070/rcr4977] [Citation(s) in RCA: 9] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Abstract
The review aims to draw attention to the latest advances in the organoboron chemistry and therapeutic use of organoboron compounds. The synthetic strategies towards boron-containing compounds with proven in vitro and/or in vivo biological activities, including derivatives of boronic acids, benzoxaboroles, benzoxaborines and benzodiazaborines, are summarized. Approaches to the synthesis of hybrid structures containing an organoboron moiety as one of the pharmacophores are considered, and the effect of this modification on the pharmacological activity of the initial molecules is analyzed. On the basis of analysis of the published data, the most promising areas of research in the field of organoboron compounds are identified, including the latest methods of synthesis, modification and design of effective therapeutic agents.
The bibliography includes 246 references.
Collapse
|
5
|
Melanson JA, Landry MF, Lanteigne M, McQuillan K, Correa H, Kerr RG, Westcott SA. Boron-containing capsaicinoids. RSC Adv 2021; 11:24282-24291. [PMID: 35479014 PMCID: PMC9036659 DOI: 10.1039/d1ra04943g] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/25/2021] [Accepted: 07/06/2021] [Indexed: 11/21/2022] Open
Abstract
This study reports on the preparation of eight new boron-containing capsaicinoids bearing long aliphatic chains, and initial bioactivities are reported.
Collapse
Affiliation(s)
| | - Maxim F. Landry
- Department of Chemistry and Biochemistry
- Mount Allison University
- Sackville
- Canada
| | - Martin Lanteigne
- Nautilus Biosciences CRODA Canada Inc
- Duffy Research Centre
- Charlottetown
- Canada
| | - Katherine McQuillan
- Nautilus Biosciences CRODA Canada Inc
- Duffy Research Centre
- Charlottetown
- Canada
| | - Hebelin Correa
- Nautilus Biosciences CRODA Canada Inc
- Duffy Research Centre
- Charlottetown
- Canada
| | - Russell G. Kerr
- Department of Chemistry
- University of Prince Edward Island
- Charlottetown
- Canada
| | - Stephen A. Westcott
- Department of Chemistry and Biochemistry
- Mount Allison University
- Sackville
- Canada
| |
Collapse
|
6
|
Combined infrared spectroscopic and computational study on simpler capsaicin derivatives and their anion intermediates in the scavenging of free radicals. Chem Phys 2020. [DOI: 10.1016/j.chemphys.2020.110763] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/31/2022]
|
7
|
Wang ZC, Wei B, Pei FN, Yang T, Tang J, Yang S, Yu LF, Yang CG, Yang F. Capsaicin derivatives with nitrothiophene substituents: Design, synthesis and antibacterial activity against multidrug-resistant S. aureus. Eur J Med Chem 2020; 198:112352. [PMID: 32387838 DOI: 10.1016/j.ejmech.2020.112352] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/27/2020] [Revised: 04/16/2020] [Accepted: 04/16/2020] [Indexed: 10/24/2022]
Abstract
To address the emergency caused by multi-drug resistant Staphylococcus aureus, a series of novel capsaicin derivatives with nitrothiophene substituents have been designed and evaluated for the antibacterial activities against S. aureus Newman and multidrug-resistant strains (NRS-1, NRS-70, NRS-100, NRS-108, and NRS-271). The structure-activity relationship was further revealed. Compound 13c, 13f, and 13g were highly active against staphylococcal growth, with minimal inhibition concentration (MIC) values of 0.39-1.56 μg/mL. The oxadiazole-derived compound 21, a bioisostere of ester 13f, is the most potent candidate for anti-growth of five multidrug-resistant S. aureus strains with MICs of 0.20-0.78 μg/mL, which is more active compared with vancomycin in vitro. Notably, these anti-staphylococcal compounds are much less cytotoxic to the normal kidney epithelial cell line (HK293T).
Collapse
Affiliation(s)
- Zhi-Cheng Wang
- Shanghai Engineering Research Center of Molecular Therapeutics and New Drug Development, SCME, East China Normal University, Shanghai, 200062, China
| | - Bingyan Wei
- State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China; University of the Chinese Academy of Sciences, Beijing, 100049, China
| | - Fang-Ning Pei
- Shanghai Engineering Research Center of Molecular Therapeutics and New Drug Development, SCME, East China Normal University, Shanghai, 200062, China
| | - Teng Yang
- State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China; State Key Laboratory Breeding Base of Green Pesticide and Agricultural Bioengineering, Key Laboratory of Green Pesticide and Agricultural Bioengineering, Ministry of Education, Center for R&D of Fine Chemicals, Guizhou University, 2708 South Huaxi Road, Guiyang, Guizhou, 550025, China
| | - Jie Tang
- Shanghai Engineering Research Center of Molecular Therapeutics and New Drug Development, SCME, East China Normal University, Shanghai, 200062, China
| | - Song Yang
- State Key Laboratory Breeding Base of Green Pesticide and Agricultural Bioengineering, Key Laboratory of Green Pesticide and Agricultural Bioengineering, Ministry of Education, Center for R&D of Fine Chemicals, Guizhou University, 2708 South Huaxi Road, Guiyang, Guizhou, 550025, China
| | - Li-Fang Yu
- Shanghai Engineering Research Center of Molecular Therapeutics and New Drug Development, SCME, East China Normal University, Shanghai, 200062, China
| | - Cai-Guang Yang
- State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China; University of the Chinese Academy of Sciences, Beijing, 100049, China.
| | - Fan Yang
- Shanghai Engineering Research Center of Molecular Therapeutics and New Drug Development, SCME, East China Normal University, Shanghai, 200062, China.
| |
Collapse
|